8 results on '"Takumi Fukumoto"'
Search Results
2. Assessment of serum and drain fluid bilirubin concentrations in liver transplantation patients
- Author
-
Hirotoshi Soyama, Kaori Kuramitsu, Masahiro Kido, Shohei Komatsu, Hidetoshi Gon, Kenji Fukushima, Takeshi Urade, Shinichi So, Yoshihide Nanno, Daisuke Tsugawa, Tadahiro Goto, Hiroaki Yanagimoto, Sadaki Asari, Hirochika Toyama, Tetsuo Ajiki, and Takumi Fukumoto
- Subjects
Transplantation ,Surgery - Abstract
Bile leakage is a major complication after liver transplantation and remains as a significant source of morbidity and mortality. In 2011, the International Study Group of Liver Surgery (ISGLS) defined bile leakage as a drain/serum bilirubin ratio ≥3. However, to our knowledge there is no literature assessing serum and drain bilirubin concentrations after liver transplantation. The aim of this study was to describe the natural postoperative changes in serum and drain fluid bilirubin concentrations in patients after liver transplantation.We included 32 patients who underwent liver transplantation at Kobe University Hospital from January 2007 to December 2020. We enrolled 34 living donors who had no complications as the control group.The recipient serum total/direct bilirubin concentration were higher compared with the donors from postoperative day (POD) 1 to 5 with a statistical difference (P.05). The recipient drain/serum total bilirubin ratio was lower than donors on POD 3 (0.89 ± 0.07 vs 1.53 ± 0.07: P.0001), which was also confirmed by the recipient drain/serum direct bilirubin ratio (0.64 ± 0.10 vs 1.18 ± 0.09: P.0001). On POD 3, the drain fluid volume (647.38 ± 89.47 vs 113.43 ± 86.8 mL: P.001) and serum total bilirubin concentration (6.73 ± 0.61 vs 1.23 ± 0.60 mg/dL: P.001) was higher in the recipients than in donors. Categorized in 2 groups, the higher drain fluid volume and bilirubin concentration recipients showed lower drain/serum total bilirubin ratio compared with the other group (P = .03) CONCLUSION: The drain/serum bilirubin ratio in the transplanted patients could be calculated lower compared with the hepatectomy patients because of high drain fluid volume and hyperbilirubinemia. Great care should be taken when assessing the bile leakage in liver transplant recipients using the ISGLS definition.
- Published
- 2022
3. Standardization of the Side-to-Side Cavo-Caval Anastomosis in Orthotopic Liver Transplantation Based on the Causal Analysis of Outflow Obstruction
- Author
-
Masahiro Kido, Hiroaki Yanagimoto, Yoshihide Nanno, Hironori Yamashita, Hidetoshi Gon, Takumi Fukumoto, Kaori Kuramitsu, Hirochika Toyama, Shohei Komatsu, Kenji Fukushima, Takeshi Urade, Tadahiro Goto, Tetsuo Ajiki, Takuya Mizumoto, Daisuke Tsugawa, Shinichi So, and Sadaki Asari
- Subjects
Transplantation ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Anastomosis, Surgical ,Liver transplantation ,Anastomosis ,Hepatic Veins ,Reference Standards ,Inferior vena cava ,Surgery ,Diaphragm (structural system) ,Liver Transplantation ,End Stage Liver Disease ,medicine.anatomical_structure ,medicine.vein ,cardiovascular system ,Medicine ,Humans ,Outflow ,business ,Vein ,Complication ,Causal analysis - Abstract
BACKGROUND Although liver transplantation is widely accepted as the therapeutic strategy for end-stage liver failure, complication of hepatic venous outflow obstruction remains lethal. Currently, ensuring a single wide orifice in both the graft and recipient inferior vena cava has been proposed to avoid hepatic venous outflow obstruction with no theoretical concept. METHODS We herein report a standardization technique for the reconstruction of the hepatic vein based on the causal analysis. RESULTS During the put-in process, the graft must be positioned in contact with the recipient diaphragm and slightly pushed to the cranial direction to simulate the state after abdominal closure. Because there is no extra space between the graft and diaphragm, the graft could not rotate about the anastomotic site of the inferior vena cava toward the diaphragm after abdominal closure as the intestinal pressure increases, and accordingly hepatic venous outflow obstruction does not develop. CONCLUSIONS With this concept, all transplant surgeons can successfully and easily perform hepatic vein reconstruction without total clamping of the inferior vena cava and without outflow block.
- Published
- 2020
4. Indication of Liver Transplantation in the Treatment of Newly Categorized Acute-on-Chronic Liver Failure In Japan
- Author
-
Takumi Fukumoto, Motofumi Tanaka, Shohei Komatsu, Yoshihiko Yano, Kaori Kuramitsu, and Masahiro Kido
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Liver transplantation ,Gastroenterology ,Primary outcome ,Japan ,Internal medicine ,medicine ,Humans ,Acute on chronic liver failure ,Aged ,Retrospective Studies ,Acute liver injury ,Aged, 80 and over ,Transplantation ,Univariate analysis ,business.industry ,digestive, oral, and skin physiology ,Liver failure ,Acute-On-Chronic Liver Failure ,Liver Failure, Acute ,Middle Aged ,Hepatic coma ,Liver Transplantation ,Survival Rate ,Liver ,Hepatic Encephalopathy ,Multivariate Analysis ,Prothrombin Time ,Surgery ,Female ,business - Abstract
This study aims to validate Japanese diagnostic criteria for acute-on-chronic liver failure (ACLF) and confirm the feasibility of performing transplantation.We included 60 patients with acute liver injury. Demographic and clinical features were retrospectively collected, and the primary outcome was compared among 4 types: acute liver failure (ALF) with hepatic coma (n = 23), ALF without hepatic coma (n = 12), acute liver injury (n = 20), and ACLF (n = 5). Moreover, 80 transplanted patients were enrolled to compare the difficulty of transplantation between ALF (n = 8) vs non-ALF (n = 72) patients.Seven patients in the ALF with hepatic coma group and 1 patient in the ACLF with hepatic coma group were transplanted. Ten patients who could not be registered for transplantation died. In univariate analysis, liver failure type (P.0001), total bilirubin level (P = .05), and prothrombin time internationalized ratio (P.0001) were associated with patient survival. In multivariate analysis, liver failure type was associated with patient survival (P.0001). The respective 1-, 3-, and 5-year patient survival rates were 45.9%, 45.9%, and 45.9% for ALF patients with hepatic coma; 100.0%, 100.0%, and 100.0% for ALF patients without hepatic coma and acute liver injury; and 80.0%, 80.0%, and 80.0% for ACLF patients (P.0001). Chronic liver disease did not affect operation time (P = .46) and bleeding volume (P = .49).Patients diagnosed with ACLF via Japanese criteria presented significantly higher survival rates than ALF patients with hepatic coma.
- Published
- 2020
5. Impact of Albumin-Bilirubin Score on Short- and Long-Term Survival After Living-Donor Liver Transplantation: A Retrospective Study
- Author
-
Hidetoshi Gon, Tetsuo Ajiki, Shohei Komatsu, Hiroaki Yanagimoto, Kaori Kuramitsu, Masahide Awazu, Kentaro Tai, Masahiro Kido, Shinichi So, Sachio Terai, Hideyo Mukubo, Motofumi Tanaka, Hirochika Toyama, Takumi Fukumoto, and Daisuke Tsugawa
- Subjects
Adult ,Male ,medicine.medical_specialty ,Multivariate analysis ,Bilirubin ,medicine.medical_treatment ,Liver transplantation ,Gastroenterology ,chemistry.chemical_compound ,Liver disease ,Liver Function Tests ,Internal medicine ,medicine ,Living Donors ,Humans ,Serum Albumin ,Retrospective Studies ,Transplantation ,business.industry ,Albumin ,Retrospective cohort study ,Middle Aged ,medicine.disease ,Prognosis ,Liver Transplantation ,Survival Rate ,chemistry ,Hepatocellular carcinoma ,Multivariate Analysis ,Surgery ,Female ,business ,Living donor liver transplantation ,Biomarkers - Abstract
Background The albumin-bilirubin (ALBI) grade, stratified from the ALBI score, may have prognostic value in patients with hepatocellular carcinoma. We aim to evaluate the prognostic abilities of the ALBI score/grade among living-donor liver transplantation patients. Methods We retrospectively collected data of 81 patients who underwent living-donor liver transplant at Kobe University Hospital between June 2000 and October 2018. The efficacy of the ALBI score/grade as a prognostic factor was assessed and compared with that of the well-established Model for End-Stage Liver Disease (MELD) score. Main findings Multivariate analysis indicated that recipient age (P = .003), donor age (P = .003), ALBI score ≥ -1.28 (P = .002), and ALBI grade III (P = .004) were independently associated with post-transplant survival. A high MELD score was not associated with post-transplant survival in univariate or multivariate analyses. Although there was no significant difference in the overall survival rate relative to recipient and donor age, ALBI score/grade was significantly associated with the 1- and 5-year survival rates (P = .023, P = .005). ALBI scores specifically detected fatal complications of post-transplant graft dysfunction (P = .031) and infection (P = .020). Conclusion ALBI score/grade predicted patient survival more precisely than the MELD score did, suggesting that it is a more useful prognostic factor compared to the MELD score in living-donor liver transplantation cases.
- Published
- 2019
6. Long-term complications after liver transplantation
- Author
-
Kaori Kuramitsu, Masahiro Tominaga, Ippei Matsumoto, Takeshi Iwasaki, Y. Ku, Takumi Fukumoto, and Tetsuo Ajiki
- Subjects
Adult ,medicine.medical_specialty ,medicine.medical_treatment ,Renal function ,Liver transplantation ,Gastroenterology ,Internal medicine ,Cause of Death ,medicine ,Outpatient clinic ,Humans ,Aged ,Transplantation ,Univariate analysis ,business.industry ,Odds ratio ,Middle Aged ,medicine.disease ,Tissue Donors ,Surgery ,Liver Transplantation ,business ,Complication ,Dyslipidemia ,Glomerular Filtration Rate - Abstract
Background Along with an increased number of cases of liver transplantation (LT), perioperative mortality has decreased and short-term survival has improved. However, long-term complications have not been fully elucidated today. Purpose Chronic complications were analyzed individually to find risk factors and to improve long-term outcomes after LT. Subjects There were 63 cases of LT from our outpatient clinic that were included in this study. Among them, 58 were performed using living donor LT and 5 were performed using deceased donor LT. Original diseases mainly consisted of hepatitis C virus (HCV; 45.9%) and hepatitis B virus (23.0%). Findings The median follow-up was 5.4 ± 3.3 years (range, 0.1∼17 years). Overall survival at 2, 3, 5, and 10 years was 89.3%, 83.4%, 81.3%, and 81.3%, respectively. Long-term complications mainly consisted of renal dysfunction (62.7%), dyslipidemia (29.4%), diabetes mellitus (21.6%), and arterial hypertension (21.6%). In univariate analysis, HCV (P = .03) and elapsed years after LT (P = .02) were identified as predictive factors for arterial hypertension and recipient age >50 (P = .03), and elapsed years after LT for renal dysfunction (P = .03), respectively. In multivariate Cox regression analysis, HCV (odds ratio [OR] 5.25, 95% confidence interval [CI] 1.05–34.06, P = .04) was identified as a predictive factor for arterial hypertension, and recipient age older than 50 years for renal dysfunction (OR 5.67, 95% CI 1.34–28.88, P = .02). The number of elapsed years after transplantation was also identified as a predictive factor for arterial hypertension/dyslipidemia/renal dysfunction (OR 13.88/14.15/4.10, 95% CI 1.91–298.26/2.18–290.78/1.09–18.03, P = .01/.003/.04). Fifty percent of the recipients developed renal dysfunction within 8 years after LT, and fluctuation of estimated glomerular filtration rate (eGFR) within 3 months after LT was successfully associated with an annual decrease of eGFR (r2 value = 0.574, P Conclusion Renal dysfunction is the most frequent chronic complication after LT. As chronic individual eGFR can be now accurately predicted with deterioration speed, recipient strata for renal protection strategies should be precisely targeted.
- Published
- 2013
7. Functioning pancreas graft with thromboses of splenic and superior mesenteric arteries after simultaneous pancreas-kidney transplantation: a case report
- Author
-
Y. Ku, Tadahiro Goto, Ippei Matsumoto, Sachiyo Shirakawa, Makoto Shinzeki, Tetsuo Ajiki, Takumi Fukumoto, and Sadaki Asari
- Subjects
Adult ,medicine.medical_specialty ,medicine.medical_treatment ,Pancreas transplantation ,Splenic artery ,Inferior vena cava ,Gastroduodenal artery ,medicine.artery ,medicine ,Humans ,Superior mesenteric artery ,Transplantation ,Common hepatic artery ,business.industry ,Thrombosis ,Kidney Transplantation ,Surgery ,Mesenteric Arteries ,surgical procedures, operative ,medicine.anatomical_structure ,medicine.vein ,Splenic vein ,Female ,Radiology ,Pancreas Transplantation ,business ,Pancreas - Abstract
Graft thrombosis is the most common cause of early graft loss after pancreas transplantation. The grafted pancreas is difficult to salvage after complete thrombosis, especially arterial thrombosis, and graft pancreatectomy is required. We describe a patient presenting with a functioning pancreas graft with thromboses of the splenic artery (SA) and superior mesenteric artery (SMA) after simultaneous pancreas-kidney transplantation (SPK). A 37-year-old woman with a 20-year history of type 1 diabetes mellitus underwent SPK. The pancreaticoduodenal graft was implanted in the right iliac fossa with enteric drainage. A Carrel patch was anastomosed to the recipient's right common iliac artery, and the graft gastroduodenal artery was anastomosed to the common hepatic artery using an arterial I-graft. The donor portal vein was anastomosed to the recipient's inferior vena cava. Four days after surgery, graft thromboses were detected by Doppler ultrasound without increases in the serum amylase and blood glucose levels. Contrast enhanced computed tomography revealed thromboses in the SA, splenic vein and SMA. Selective angiography showed that blood flow was interrupted in the SA and SMA. However, pancreatic graft perfusion was maintained by the I-graft in the head of the pancreas and the transverse pancreatic artery in the body and tail of the pancreas. We performed percutaneous direct thrombolysis and adjuvant thrombolytic therapy. However, we had to stop the thrombolytic therapy because of gastrointestinal hemorrhage. Thereafter, the postoperative course was uneventful and the pancreas graft was functioning with a fasting blood glucose level of 75 mg/dL, HbA1c of 5.1%, and serum C-peptide level of 1.9 ng/mL at 30 months post-transplantation.
- Published
- 2013
8. Evaluation of glucose metabolism after distal pancreatectomy according to the donor criteria of the living donor pancreas transplantation guidelines proposed by the Japanese Pancreas and Islet Transplantation Association
- Author
-
Sachiyo Shirakawa, Yonson Ku, Tadahiro Goto, Makoto Shinzeki, Ippei Matsumoto, Tetsuo Ajiki, Takumi Fukumoto, and Sadaki Asari
- Subjects
Male ,medicine.medical_specialty ,medicine.medical_treatment ,Islets of Langerhans Transplantation ,Pancreas transplantation ,Gastroenterology ,Pancreatectomy ,Japan ,Internal medicine ,Diabetes mellitus ,Living Donors ,Medicine ,Humans ,Dialysis ,Societies, Medical ,Transplantation ,geography ,geography.geographical_feature_category ,business.industry ,Odds ratio ,Middle Aged ,Islet ,medicine.disease ,Tissue Donors ,Surgery ,medicine.anatomical_structure ,Glucose ,Practice Guidelines as Topic ,Female ,Hemoglobin ,Pancreas Transplantation ,business ,Pancreas - Abstract
Background Living donor pancreas transplantation (LDPT) reduces the number of deaths of diabetic patients on dialysis and of candidates on the waiting lists and helps to overcome the organ shortage. Stringent criteria must be applied to minimize the risk of metabolic complications for living donors. The Japanese Pancreas and Islet Transplantation Association (JPITA) proposed LDPT guidelines in 2010. In this study, we retrospectively evaluated glucose metabolism of the patients who underwent distal pancreatectomy (DP) according to the donor criteria of the LDPT guidelines proposed by the JPITA. Methods Fifty-two nondiabetic patients who underwent DP were divided into 2 groups according to the donor criteria: indication group (IG, n = 14) who had age ≤ 65, hemoglobin A1c (HbA1c) 2 . The other patients were placed in the no indication group (NG, n = 38). Clinical data and percent resected volume (PRV) of each pancreas as determined by multi–detector row computed tomography volumetry were compared between the 2 groups. Results During the follow-up period (median 12 months), 14 patients (27%) developed new-onset diabetes within a median onset time of 10 months (range 3–24 months) postoperatively. No patient in the IG developed new-onset diabetes. On the other hand, 37% of the patients in the NG developed new-onset diabetes. There were significant between-group differences in changes in preoperative serum fasting glucose and HbA1c levels, whereas there were no significant between-group differences in preoperative serum albumin or body weight. Multivariate analysis identified preoperative HbA1c (odds ratio 51.6, P = .002) and PRV (odds ratio 2.07, P = .033) as independent risk factors for new-onset diabetes. Conclusion Living donor criteria in the LDPT guidelines proposed by the JPITA are appropriate for prevention of glucose metabolic complications in donors. Further long-term follow-up studies of living donors' metabolic function are needed to clarify the safety of the donor.
- Published
- 2013
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.